PubMed ID: 15287370
Author(s): Thibodeaux BA, Dajcs JJ, Caballero AR, Marquart ME, Girgis DO, O’Callaghan RJ. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. Curr Eye Res. 2004 May;28(5):337-42. PMID 15287370
Journal: Current Eye Research, Volume 28, Issue 5, May 2004
PURPOSE To determine the effectiveness of topically applied fluoroquinolones for experimental Pseudomonas or Serratia keratitis.
METHODS Bacteria were injected intrastromally (10(3) colony forming units [CFU]). From 16 to 22 hours post-infection (PI), a single topical drop of moxifloxacin (Vigamox, 0.545%), levofloxacin (Quixin, 0.5%), ofloxacin (Ocuflox, 0.3%) or ciprofloxacin (Ciloxan, 0.3%) was applied every 30 minutes. At 23 hours PI, corneas were cultured quantitatively.
RESULTS For Pseudomonas keratitis, untreated eyes contained 7 log CFU/cornea and antibiotic-treated eyes demonstrated a > or = 5-log reduction in CFU/cornea (p or = 0.67). For Serratia keratitis, untreated eyes contained 7 logCFU/cornea whereas treated eyes had a > or = 2-log reduction (p < or = 0.0001). Moxifloxacin therapy proved most effective (p < or = 0.001).
CONCLUSIONS Overall, moxifloxacin was the most effective of the four fluoroquinolones in reducing CFU/cornea in the rabbit model of gram-negative keratitis.